Beta2 (ß2)-agonist ... and chronic cough. ß2-agonists relax the smooth muscles of the airways to relieve these symptoms. Both ...

Cap colors can be misplaced on the wrong inhaler by mistake. Green inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory ...

Among those patients who used a controller medication before starting an LABA, other controller medications were used more frequently than inhaled corticosteroids. We compared controller use ...

[3] So I knew there was a trend toward using as-needed inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA) combination therapy in lieu of SABAs. I didn't expect the 2019 Global Initiative ...

The GoResp Digihaler – which delivers inhaled corticosteroid budesonide and long-acting beta agonist formoterol – has built-in sensors that detect and record data on a patient’s use and ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Labor & delivery. Pregnancy. Nursing mothers. Long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma can increase risk of asthma-related death.

Avoid Excessive Use of Advair HFA and Avoid Use with Other Long-acting Beta2-agonists Do not exceed the recommended dose. Fatalities have been reported with excessive use of inhaled ...

The combination of an inhaled corticosteroid, long-acting muscarinic antagonist, and a long-acting beta2 adrenergic agonist is important to GSK as it must replace lost sales from its ageing ...

SYMBICORT is a newly approved, twice-daily, inhaled combination therapy containing budesonide, a corticosteroid, and formoterol, a rapid and long-acting beta2-agonist. It is indicated for the long ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...